Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis

Summary This study aimed to assess the fibrinolytic inhibitors and their association with thrombosis in Behçet disease. Thrombin activatable fibrinolysis inhibitor (TAFI) (P

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2008-06, Vol.141 (5), p.716-719
Hauptverfasser:	Ricart, José M., Ramón, Luis A., Vayá, Amparo, España, Francisco, Santaolaria, Maria‐Luisa, Todolí, José, Castelló, Remedios, Fontcuberta, Jordi, Estellés, Amparo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Behcet Syndrome - blood Behcet Syndrome - genetics Behçet disease Biological and medical sciences Blood Glucose - analysis Carboxypeptidase B2 - blood Female Fibrinolysis fibrinolytic inhibitors Genetic Predisposition to Disease Hematologic and hematopoietic diseases Humans Lipids - blood Male Medical sciences Middle Aged plasminogen activator inhibitor 1 Plasminogen Activator Inhibitor 1 - blood Polymorphism, Genetic Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis thrombin activatable fibrinolysis inhibitor Thrombosis - blood Thrombosis - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Summary This study aimed to assess the fibrinolytic inhibitors and their association with thrombosis in Behçet disease. Thrombin activatable fibrinolysis inhibitor (TAFI) (P
ISSN:	0007-1048 1365-2141
DOI:	10.1111/j.1365-2141.2008.07078.x